Remacha A F, Oliver A, Calero F, Barceló M J, Doñate T, Ballarín J A, García-Die F
Servicio de Hematología, Hospital de la Santa Creu i Sant Pau, Barcelona.
Med Clin (Barc). 1992 Jun 20;99(4):125-7.
In order to know the influence of dialysis treatment in erythropoietin production, serum erythropoietin (Ep) has been studied in patients with anemia due to chronic renal failure (CRF).
Thirty six of them in hemodialysis (HD), 10 in continuous ambulatory peritoneal dialysis (CAPD) and 18 in predialysis stage (PD) and their results were compared to two control groups, including 72 healthy controls (HC) and the second one 89 iron deficiency anemia patients (ID).
Patients had lower Hb and Ep levels than the other groups. Although Ep was higher in CAPD and PD. Ep levels were similar to HC values, and lower than ID levels. It could be demonstrated any correlation between Hb and Ep in CRF patients, however a negative exponential correlation was demonstrated in ID patients between Hb and Ep (r = -0.83; p less than 0.00001). In summary, Ep is higher in CAPD and in PD than in HD, but the levels are lower than they should be expected.
These data confirm an Ep production failure in most of IRC patients and it seems likely that Ep treatment could be effective to treat the anemia of CRF.
为了解透析治疗对促红细胞生成素产生的影响,对慢性肾衰竭(CRF)所致贫血患者的血清促红细胞生成素(Ep)进行了研究。
选取36例血液透析(HD)患者、10例持续性非卧床腹膜透析(CAPD)患者和18例透析前阶段(PD)患者,将其结果与两个对照组进行比较,其中一个对照组为72例健康对照者(HC),另一个对照组为89例缺铁性贫血患者(ID)。
患者的血红蛋白(Hb)和Ep水平低于其他组。虽然CAPD组和PD组的Ep较高,但Ep水平与HC组相似,且低于ID组。CRF患者中Hb与Ep之间未显示出相关性,然而在ID患者中Hb与Ep之间呈负指数相关(r = -0.83;p < 0.00001)。总之,CAPD组和PD组的Ep高于HD组,但水平低于预期。
这些数据证实大多数CRF患者存在促红细胞生成素生成障碍,促红细胞生成素治疗可能对治疗CRF贫血有效。